Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvnne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)
Wegovy is the first-and-only medication indicated for both chronic weight management and to reduce the risk of non-fatal myocardial infarction (MI) in Canada
Another group (area D) had low serum L-carnitine levels, which are caused by low de novo synthesis of L-carnitine, which might be improved through dietary administration of L-carnitine
There is also a psychological dimension to consider